Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein

E Kerkhoff, LM Fedorov, R Siefken, AO Walter… - 2000 - AACR
E Kerkhoff, LM Fedorov, R Siefken, AO Walter, T Papadopoulos, UR Rapp
2000AACR
The c-Raf-1 kinase is a downstream effector of Ras signaling. Both proteins are highly
oncogenic when they are mutationally activated, but only the Ras GTPase is frequently
mutated in naturally occurring tumors. Although the c-Raf-1 protein was found to be
amplified in different lung cancer cell lines, overexpression of the wild-type c-Raf-1 protein
was shown to be insufficient to transform cultured cells. Here we have addressed the
question of whether overexpression of the wild-type c-Raf-1 kinase can induce lung cancer …
Abstract
The c-Raf-1 kinase is a downstream effector of Ras signaling. Both proteins are highly oncogenic when they are mutationally activated, but only the Ras GTPase is frequently mutated in naturally occurring tumors. Although the c-Raf-1 protein was found to be amplified in different lung cancer cell lines, overexpression of the wild-type c-Raf-1 protein was shown to be insufficient to transform cultured cells. Here we have addressed the question of whether overexpression of the wild-type c-Raf-1 kinase can induce lung cancer in mice. We show that lung-targeted expression of oncogenically activated or wild-type c-Raf-1 proteins induces morphologically indistinguishable lung adenomas in transgenic mice. Compared with mice transgenic for the activated c-Raf-1-BxB, tumor development is delayed and occurs at a lower incidence in wild-type c-Raf-1 transgenic mice. Our studies show that the c-Raf-1 expression level is a critical parameter in tumor development and should be analyzed in more detail to evaluate its potential in the induction of cancer.
AACR